Immunovia AB (publ) (IMMVF) Research

Immunovia AB (publ) is a Swedish diagnostics firm that develops and commercializes blood tests for markets both within Sweden and worldwide. Its flagship product is IMMray PanCan-d, an innovative blood-based assay specifically designed for the early identification of pancreatic cancer. Beyond this, the company also conducts research initiatives into lung cancer. Established in 2007, Immunovia AB (publ) maintains its corporate headquarters in Lund, Sweden.

Market snapshot

Symbol
IMMVF
Price
$0.02
Day change
0.00%
Market cap
$65.7M
P/E ratio
-1.21x
52-week range
0.02-0.15
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 2 months

Peer companies

  • CelLBxHealth plc (ANPCY)
  • Aurora Spine Corporation (ASAPF)
  • Cell Source, Inc. (CLCS)
  • Many Bright Ideas Technologies Inc. (MBGNF)
  • OpGen, Inc. (OPGN)
  • Propanc Biopharma, Inc. (PPCB)
  • RYAH Group, Inc. (RYAHF)
  • Synairgen plc (SYGGF)

Open Immunovia AB (publ) (IMMVF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.